Dyne Issuance Of Capital Stock from 2010 to 2024
| DYN Stock | USD 26.00 0.05 0.19% |
Issuance Of Capital Stock | First Reported 2010-12-31 | Previous Quarter 89.2 M | Current Value 126.9 M | Quarterly Volatility 101.7 M |
Check Dyne TherapeuticsInc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dyne main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.3 M, Interest Expense of 2.5 M or Selling General Administrative of 29.8 K, as well as many exotic indicators such as Price To Sales Ratio of 6.54, Dividend Yield of 0.0 or PTB Ratio of 9.13. Dyne financial statements analysis is a perfect complement when working with Dyne TherapeuticsInc Valuation or Volatility modules.
Dyne | Issuance Of Capital Stock |
Latest Dyne TherapeuticsInc's Issuance Of Capital Stock Growth Pattern
Below is the plot of the Issuance Of Capital Stock of Dyne TherapeuticsInc over the last few years. It is Dyne TherapeuticsInc's Issuance Of Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dyne TherapeuticsInc's overall financial position and show how it may be relating to other accounts over time.
| Issuance Of Capital Stock | 10 Years Trend |
|
Issuance Of Capital Stock |
| Timeline |
Dyne Issuance Of Capital Stock Regression Statistics
| Arithmetic Mean | 58,542,727 | |
| Geometric Mean | 20,055,597 | |
| Coefficient Of Variation | 173.79 | |
| Mean Deviation | 69,376,266 | |
| Median | 7,422,000 | |
| Standard Deviation | 101,740,468 | |
| Sample Variance | 10351.1T | |
| Range | 373.8M | |
| R-Value | 0.51 | |
| Mean Square Error | 8299.4T | |
| R-Squared | 0.26 | |
| Significance | 0.05 | |
| Slope | 11,498,933 | |
| Total Sum of Squares | 144915.7T |
Dyne Issuance Of Capital Stock History
About Dyne TherapeuticsInc Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Dyne TherapeuticsInc income statement, its balance sheet, and the statement of cash flows. Dyne TherapeuticsInc investors use historical funamental indicators, such as Dyne TherapeuticsInc's Issuance Of Capital Stock, to determine how well the company is positioned to perform in the future. Although Dyne TherapeuticsInc investors may use each financial statement separately, they are all related. The changes in Dyne TherapeuticsInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Dyne TherapeuticsInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Dyne TherapeuticsInc Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Dyne TherapeuticsInc. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Issuance Of Capital Stock | 89.2 M | 126.9 M |
Pair Trading with Dyne TherapeuticsInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dyne TherapeuticsInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyne TherapeuticsInc will appreciate offsetting losses from the drop in the long position's value.Moving against Dyne Stock
| 0.69 | RGC | Regencell Bioscience | PairCorr |
| 0.64 | IRWD | Ironwood Pharmaceuticals | PairCorr |
| 0.55 | ITCI | Intracellular Th | PairCorr |
| 0.52 | INBX | InhibrxInc Financial Report 13th of May 2024 | PairCorr |
| 0.5 | LFCR | Lifecore Biomedical Financial Report 6th of June 2024 | PairCorr |
The ability to find closely correlated positions to Dyne TherapeuticsInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dyne TherapeuticsInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dyne TherapeuticsInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dyne TherapeuticsInc to buy it.
The correlation of Dyne TherapeuticsInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dyne TherapeuticsInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dyne TherapeuticsInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dyne TherapeuticsInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Dyne TherapeuticsInc Correlation against competitors. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne TherapeuticsInc guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for Dyne Stock analysis
When running Dyne TherapeuticsInc's price analysis, check to measure Dyne TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dyne TherapeuticsInc is operating at the current time. Most of Dyne TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Dyne TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dyne TherapeuticsInc's price. Additionally, you may evaluate how the addition of Dyne TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |
Is Dyne TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dyne TherapeuticsInc. If investors know Dyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dyne TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.98) | Return On Assets (0.41) | Return On Equity (0.71) |
The market value of Dyne TherapeuticsInc is measured differently than its book value, which is the value of Dyne that is recorded on the company's balance sheet. Investors also form their own opinion of Dyne TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Dyne TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dyne TherapeuticsInc's market value can be influenced by many factors that don't directly affect Dyne TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dyne TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dyne TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dyne TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.